Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2011 Apr;121(4):1253-5. doi: 10.1172/JCI57229. Epub 2011 Mar 23.

Niche competition and cancer metastasis to bone.

Author information

1
Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

Abstract

The molecular basis for the preferential metastases of certain cancers to bone is not well understood. In this issue of the JCI, Shiozawa et al. provide compelling evidence that prostate cancer cells preferentially home to the osteoblastic niche in the bone marrow, where they compete with normal HSCs for niche support. Because signals from the niche may regulate tumor quiescence and sensitivity to chemotherapy, these observations have important implications for the treatment of metastatic prostate cancer in bone.

PMID:
21436576
PMCID:
PMC3069798
DOI:
10.1172/JCI57229
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Society for Clinical Investigation Icon for PubMed Central
    Loading ...
    Support Center